Skip to content

Stock-Based Comp at other companies

Procter & Gamble logo
Procter & GamblePG
$132M+7.3%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$300M+4.2%
Bausch Health Companies logo
Bausch Health CompaniesBHC
$52M+20.9%
Cencora logo
CencoraCOR
$28M-1.6%
Cardinal Health logo
Cardinal HealthCAH
$129M+316%
Organon logo
OrganonOGN
$19M-20.8%

Other financials

Income statement

See full
Revenue$281.6M-5.0%
Gross profit$146.3M-13.9%
Operating income$75.5M-14.6%
Net income$53.9M+7.6%
EPS (diluted)$1.13+11.9%

Balance sheet

See full
Cash & equivalents$63.9M-34.8%
Total debt$1.0B-0.2%
Total equity$1.9B+2.9%
Total assets$3.5B+2.7%

Cash flow

See full
Operating cash flow$42.8M-30.7%
CapEx$5.2M+49.8%
Free cash flow$37.6M-35.5%

Valuation

See full
Market cap$2.18B-34.1%
Enterprise value$3.16B-27.3%
P/E11.5×-4.0×
P/S-0.9×

Profitability

See full
Gross margin54.7%-1.1pp
Operating margin28.4%-1.2pp
Net margin17.5%-1.4pp
FCF margin22.6%+1.3pp

Returns & leverage

See full
Return on equity10.2%-2.1pp
Debt / equity0.6×0.0×
Current ratio3.6×-0.6×

Where this comes from

Reported directly by Prestige Consumer Healthcare in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Prestige Consumer Healthcare’s 10-K, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prestige Consumer Healthcare's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Prestige Consumer Healthcare's stock-based comp?
Prestige Consumer Healthcare (PBH) reported stock-based comp of $2.65M in Q1 2026.
How has Prestige Consumer Healthcare's stock-based comp changed year-over-year?
Prestige Consumer Healthcare's stock-based comp decreased by 3.1% year-over-year, from $2.73M to $2.65M.
What is the long-term trend for Prestige Consumer Healthcare's stock-based comp?
Over 4 years (2022 to 2026), Prestige Consumer Healthcare's stock-based comp has grown at a 4.6% compound annual growth rate (CAGR), from $9.04M to $10.84M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.